Who We Are
The Haystead Laboratory at Duke University School of Medicine is dedicated to discovering and developing molecular tools that improve how we diagnose and treat disease.
Our work centers on designing small-molecule inhibitors and radiolabeled probes that enable precision PET imaging and targeted therapy in cancer and infection. By combining chemical synthesis, molecular biology, imaging science, and computational modeling, we translate mechanistic discoveries into impactful diagnostic and therapeutic platforms.
Highlights
Our Research
We develop molecular probes and radiolabeled therapeutics to better understand, detect, and treat disease. Our research is grounded in rigorous experimental design, quantitative validation, and a commitment to reproducibility and translational impact.
Our Projects
We maintain a broad and evolving research portfolio across molecular imaging, radiophysics, computational simulation, and in vivo experimentation, bridging mechanistic discovery with translational application.
Our Team
We are a team of enthusiasitc researchers uniting faculty, postdoctoral scholars, staff scientists, and trainees across chemistry, biology, medical physics, and computational sciences to push the boundries of therapeautic and imaging drugs.